Moreover, NRF2 was seen to promote oncogenic K-RasG12D-initiated tumor formation and proliferation of pancreatic and lung cancers in vivo and K-RasG12D, BRAF V619E, and MYC-induced NRF2 transcription [14,165]. The gene discussed is NFE2L2; the disease is lung carcinoma.